TSC/MTOR Mutated Renal Cell Carcinoma with Leiomyomatous Stroma is a Distinct Entity: A Comprehensive Study of 12 Cases.

[1]  J. Cheville,et al.  Lessons From Histopathologic Examination of Nephrectomy Specimens in Patients with Tuberous Sclerosis Complex: Cysts, Angiomyolipomas & Renal Cell Carcinoma. , 2022, Human pathology.

[2]  M. Rubin,et al.  The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. , 2022, European urology.

[3]  J. Cheville,et al.  New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia , 2021, Modern Pathology.

[4]  J. Cheville,et al.  Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia , 2021, Modern Pathology.

[5]  J. Cheville,et al.  Renal Neoplasia in Tuberous Sclerosis: A Study of 41 Patients. , 2021, Mayo Clinic proceedings.

[6]  T. Antic,et al.  TSC/MTOR mutated eosinophilic renal tumors are a distinct entity that are CK7+/CK20-/vimentin-: a validation study. , 2020, Human pathology.

[7]  P. Russo,et al.  The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management. , 2020, European urology.

[8]  T. Antic,et al.  Eosinophilic Renal Cell Tumors With a TSC and MTOR Gene Mutations Are Morphologically and Immunohistochemically Heterogenous , 2020, The American journal of surgical pathology.

[9]  K. Trpkov,et al.  ESC, ALK, HOT and LOT: Three Letter Acronyms of Emerging Renal Entities Knocking on the Door of the WHO Classification , 2020, Cancers.

[10]  R. Shah,et al.  “Renal Cell Carcinoma With Leiomyomatous Stroma” Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity , 2019, The American journal of surgical pathology.

[11]  Lauren L. Ritterhouse,et al.  Genetic Underpinnings of Renal Cell Carcinoma With Leiomyomatous Stroma , 2019, The American journal of surgical pathology.

[12]  D. Grignon,et al.  Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex. , 2017, Human pathology.

[13]  Michelle N Wurst,et al.  Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays. , 2017, The Journal of molecular diagnostics : JMD.

[14]  D. Berney,et al.  Fumarate Hydratase–deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome , 2016, The American journal of surgical pathology.

[15]  P. Humphrey,et al.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. , 2016, European urology.

[16]  N. Rioux-Leclercq,et al.  Clear cell papillary renal cell carcinoma, renal angiomyoadenomatous tumor, and renal cell carcinoma with leiomyomatous stroma relationship of 3 types of renal tumors: a review. , 2016, Annals of diagnostic pathology.

[17]  E. Thiele,et al.  Tuberous Sclerosis Complex , 2019, Harper's Textbook of Pediatric Dermatology.

[18]  D. Grignon,et al.  Renal cell carcinoma with angioleiomyoma-like stroma: clinicopathological, immunohistochemical, and molecular features supporting classification as a distinct entity , 2015, Modern Pathology.

[19]  A. Sangoi,et al.  Tuberous Sclerosis–associated Renal Cell Carcinoma: A Clinicopathologic Study of 57 Separate Carcinomas in 18 Patients , 2014, The American journal of surgical pathology.

[20]  M. Rosenblum,et al.  Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel–Lindau gene and hypoxia-inducible factor pathway-related proteins , 2011, Modern Pathology.

[21]  F. Kim,et al.  Molecular aspects of renal cell carcinoma: a review. , 2011, American journal of cancer research.

[22]  O. Hes,et al.  Difference between RAT and clear cell papillary renal cell carcinoma/clear renal cell carcinoma , 2009, Virchows Archiv.

[23]  C. Ohe,et al.  Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity , 2008, Virchows Archiv.

[24]  O. Hes,et al.  Benign renal angiomyoadenomatous tumor: a previously unreported renal tumor. , 2000, Annals of diagnostic pathology.